Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Fuminaka Sugauchi; Akihiro Tamori; Sei Kakinnuma; Kentaro Matsuura

首页> 外文期刊>Journal of Gastroenterology >Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

【24h】

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

机译：聚乙二醇干扰素α-2b联合利巴韦林联合治疗慢性丙型肝炎的贫血进展的预处理预测：决策树分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background This study aimed to develop a model to predict the development of severe anemia during pegylated interferon alpha-2b plus ribavirin combination therapy.

机译：背景本研究旨在建立一个模型，以预测聚乙二醇化干扰素α-2b加利巴韦林联合治疗期间严重贫血的发生。

著录项

来源
《Journal of Gastroenterology 》 |2011年第9期| p.1111-1119| 共9页
作者
Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Fuminaka Sugauchi; Akihiro Tamori; Sei Kakinnuma; Kentaro Matsuura;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis. [J] . Hiramatsu N, Kurosaki M, Sakamoto N, Journal of gastroenterology . 2011 ,第9期

机译：聚乙二醇干扰素α-2b联合利巴韦林联合治疗慢性丙型肝炎的贫血进展的预处理预测：决策树分析。
2. Lead-in treatment with interferon-??/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype [J] . ItokawaN., AtsukawaM., TsubotaA., Journal of gastroenterology and hepatology . 2013 ,第3期

机译：干扰素-β/利巴韦林的导入治疗可能会改变聚乙二醇化干扰素α-2b/利巴韦林联合治疗IL28B小基因型慢性丙型肝炎患者的早期丙型肝炎病毒动力学
3. Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. [J] . Hiramatsu N, Kurashige N, Oze T, Hepatology research: the official journal of the Japan Society of Hepatology . 2008 ,第1期

机译：在慢性丙型肝炎患者中，在聚乙二醇化干扰素和利巴韦林联合治疗期间，血红蛋白的早期下降可以预测溶血性贫血的进展。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection [O] . Tetsuro Takayama, Hirotoshi Ebinuma, Shinichiro Tada, 2011

机译：聚乙二醇化干扰素α-2b加利巴韦林联合治疗的效果预测治疗慢性丙型肝炎感染
7. Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection [O] . Takayama, Tetsuro, Ebinuma, Hirotoshi, Tada, Shinichiro, 2011

机译：聚乙二醇干扰素α-2b联合利巴韦林联合治疗对慢性丙型肝炎患者的疗效预测

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

摘要

著录项

相似文献

相关主题

期刊订阅